{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T15:12:14Z","timestamp":1716822734911},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chinese medical doctor association exploration cardiovascular research fund","award":["DFCMDA201203"],"award-info":[{"award-number":["DFCMDA201203"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Few studies examined the effect of long-acting nitrates on renal function in chronic heart failure (CHF). Thus, we aimed to investigate the effect of long-acting nitrate on the expression of adrenoceptors (AR) and angiotensin II receptor (ATR) subtypes of the renal cortex, in rats with myocardial infarction-induced CHF.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Rats were randomly divided into the following groups: control, sham-operated, CHF, low- and high-dose nitrate, positive drug control (olmesartan), and high-dose of long-acting nitrate + olmesartan. Ultrasound echocardiography markers were compared, and the levels of AR subtypes, AT<jats:sub>1<\/jats:sub>R, and AT<jats:sub>2<\/jats:sub>R were measured using reverse transcription-polymerase chain reaction and western blot analysis. Histopathology of the kidney was determined on hematoxylin and eosin-stained sections.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>CHF significantly increased plasma renin activity (PRA) and angiotensin II levels, upregulated AT<jats:sub>1<\/jats:sub>R expression and downregulated \u03b1<jats:sub>1A<\/jats:sub>-, \u03b2<jats:sub>1<\/jats:sub>-, \u03b2<jats:sub>2<\/jats:sub>-AR, and AT<jats:sub>2<\/jats:sub>R expression compared to the sham control. High-dose nitrate or olmesartan alone, and especially in combination, decreased the levels of PRA and angiotensin II and downregulated the CHF-induced expression of AT<jats:sub>1<\/jats:sub>R, \u03b1<jats:sub>1A<\/jats:sub>-, \u03b2<jats:sub>1<\/jats:sub>-, and \u03b2<jats:sub>2<\/jats:sub>-AR, and AT<jats:sub>2<\/jats:sub>R. CHF resulted in significant impairment of the renal tissue, including inflammatory cells infiltration to the tubular interstitium and surrounding the renal glomerulus, and tubular necrosis, which was alleviated in all treatment groups to different degrees.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Long-acting nitrates could reverse CHF-induced changes in AR and ATR subtypes in the kidney, and improve cardiac function to protect renal function. Compared with monotherapy, the combination of nitrates and olmesartan shows more significant benefits in regulating AR and ATR subtypes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-020-01353-z","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T22:18:37Z","timestamp":1582841917000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["High-dose nitrate therapy recovers the expression of subtypes \u03b11 and \u03b2-adrenoceptors and Ang II receptors of the renal cortex in rats with myocardial infarction-induced heart failures"],"prefix":"10.1186","volume":"20","author":[{"given":"Yubo","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengmeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junying","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhili","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shutian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,27]]},"reference":[{"issue":"1","key":"1353_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1463-1326.2012.01669.x","volume":"15","author":"RE Maser","year":"2013","unstructured":"Maser RE, Lenhard MJ, Kolm P, et al. Direct renin inhibition improves parasympathetic function in diabetes. Diabetes Obes Metab. 2013;15(1):28\u201334.","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"1353_CR2","first-page":"4024","volume":"7","author":"Q Zhao","year":"2014","unstructured":"Zhao Q, Huang H, Wang X, et al. Changes of serum neurohormone after renal sympathetic denervation in dogs with pacing-induced heart failure. Int J Clin Exp Med. 2014;7(11):4024.","journal-title":"Int J Clin Exp Med"},{"key":"1353_CR3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fphys.2014.00246","volume":"5","author":"C de Lucia","year":"2014","unstructured":"de Lucia C, Femminella GD, Gambino G, et al. Adrenal adrenoceptors in heart failure. Front Physiol. 2014;5:246.","journal-title":"Front Physiol"},{"issue":"6","key":"1353_CR4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/CIRCRESAHA.113.300308","volume":"113","author":"A Lymperopoulos","year":"2013","unstructured":"Lymperopoulos A, Rengo G, Koch WJ. Adrenergic nervous system in heart failure pathophysiology and therapy. Circ Res. 2013;113(6):739\u201353.","journal-title":"Circ Res"},{"issue":"5","key":"1353_CR5","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1745-7254.2008.00788.x","volume":"29","author":"A Armenia","year":"2008","unstructured":"Armenia A, Sattar MA, Abdullah NA, et al. Functional subtypes of renal \u03b11-adrenoceptor in diabetic and non-diabetic 2K1C Goldblatt renovascular hypertension. Acta Pharmacol Sin. 2008;29(5):564\u201372.","journal-title":"Acta Pharmacol Sin"},{"key":"1353_CR6","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/bjp.2008.13","volume":"153","author":"MA Hye Khan","year":"2008","unstructured":"Hye Khan MA, Sattar MA, Abdullah NA, et al. Influence of combined hypertension and renal failure on functional a1-adrenoceptor subtypes in the rat kidney. Br J Pharmacol. 2008;153:1232\u201341.","journal-title":"Br J Pharmacol"},{"key":"1353_CR7","doi-asserted-by":"crossref","unstructured":"Zhao X, Zhang Y, Leander M, et al. Altered expression profile of renaladrenergic receptor in diabetes and its modulation by PPAR agonists. J Diabetes Res. 2014;725634.","DOI":"10.1155\/2014\/725634"},{"key":"1353_CR8","first-page":"453","volume":"34","author":"W Zhu","year":"2009","unstructured":"Zhu W, Zhang X, Xiao Y. Echocardiographic evaluation of cardiac function change in heart failure rat model. J Central South Univ (Medical Sciences). 2009;34:453\u20136 chinese.","journal-title":"J Central South Univ (Medical Sciences)"},{"key":"1353_CR9","doi-asserted-by":"publisher","first-page":"e98012","DOI":"10.1371\/journal.pone.0098012","volume":"9","author":"IL Gomes-Santos","year":"2014","unstructured":"Gomes-Santos IL, Fernandes T, Couto GK, et al. Effects of exercise training on circulating and skeletal muscle renin-angiotensin system in chronic heart failure rats. PLoS One. 2014;9:e98012.","journal-title":"PLoS One"},{"issue":"5","key":"1353_CR10","doi-asserted-by":"publisher","first-page":"F775","DOI":"10.1152\/ajprenal.00233.2012","volume":"303","author":"MG Feng","year":"2012","unstructured":"Feng MG, Prieto MC, Navar LG. Nebivolol-induced vasodilation of renal afferent arterioles involves \u03b23-adrenergic receptor and nitric oxide synthase activation. Am J Physiol-Renal Physiol. 2012;303(5):F775\u201382.","journal-title":"Am J Physiol-Renal Physiol"},{"issue":"1","key":"1353_CR11","first-page":"7","volume":"21","author":"SS-TL Yan-fang","year":"2007","unstructured":"Yan-fang SS-TL, Jun L, et al. The influence of angiotensin II on positive inotropic effect mediated by cardiac \u03b11-adrenergic receptor in rats of different ages. Chinese J Pharmacol Toxicol. 2007;21(1):7\u201310 chinese.","journal-title":"Chinese J Pharmacol Toxicol"},{"issue":"12","key":"1353_CR12","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1093\/ndt\/gfp471","volume":"24","author":"MM Fung","year":"2009","unstructured":"Fung MM, Chen Y, Lipkowitz MS, et al. Adrenergic beta-1 receptor genetic variation predicts longitudinal rate of GFR decline in hypertensive nephrosclerosis. Nephrol Dial Transplant. 2009;24(12):3677 gfp471.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"1353_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10157-011-0494-1","volume":"16","author":"SM Kim","year":"2012","unstructured":"Kim SM, Briggs JP, Schnermann J. Convergence of major physiological stimuli for renin release on the Gs-alpha\/cyclic adenosine monophosphate signaling pathway [J]. Clin Exp Nephrol. 2012;16(1):17\u201324.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"1353_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3109\/03009734.2010.526723","volume":"116","author":"MH Abdulla","year":"2011","unstructured":"Abdulla MH, Sattar MA, Abdullah NA, et al. Effect of renal sympathetic nerve on adrenergically and angiotensin II-induced renal vasoconstriction in normal Wistar-Kyoto rats [J]. Ups J Med Sci. 2011;116(1):18\u201325.","journal-title":"Ups J Med Sci"},{"key":"1353_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/1470320312443720","volume":"13","author":"J Gao","year":"2012","unstructured":"Gao J, Chao J, Parbhu KJK, et al. Ontogeny of angiotensin type 2 and type 1 receptor expression in mice. J Renin-Angiotensin-Aldosterone Syst. 2012;13:341\u201352.","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"key":"1353_CR16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1177\/1470320310379065","volume":"11","author":"L Yu","year":"2010","unstructured":"Yu L, Zheng M, Wang W, et al. Developmental changes in AT1 and AT2 receptor-protein expression in rats. J Renin-Angiotensin-Aldosterone Syst. 2010;11:214\u201321.","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"key":"1353_CR17","doi-asserted-by":"publisher","first-page":"11190","DOI":"10.3390\/ijms140611190","volume":"14","author":"TV Eskildsen","year":"2013","unstructured":"Eskildsen TV, Jeppesen PL, Schneider M, et al. Angiotensin II regulates micro RNA-132\/\u2212212 in hypertensive rats and humans. Int J Mol Sci. 2013;14:11190\u2013207.","journal-title":"Int J Mol Sci"},{"key":"1353_CR18","doi-asserted-by":"publisher","first-page":"F31","DOI":"10.1152\/ajprenal.00088.2010","volume":"300","author":"SC Clayton","year":"2011","unstructured":"Clayton SC, Haack KKV, Zucker IH. Renal denervation modulates angiotensin receptor expression in the renal cortex of rabbits with chronic heart failure. Am J Physiol-Renal Physiol. 2011;300:F31\u20139.","journal-title":"Am J Physiol-Renal Physiol"},{"issue":"5","key":"1353_CR19","doi-asserted-by":"publisher","first-page":"e96353","DOI":"10.1371\/journal.pone.0096353","volume":"9","author":"M Ivanov","year":"2014","unstructured":"Ivanov M, Mihailovi\u0107-Stanojevi\u0107 N, Milanovi\u0107 JG, et al. Losartan improved antioxidant defense, renal function and structure of postischemic hypertensive kidney [J]. PLoS One. 2014;9(5):e96353.","journal-title":"PLoS One"},{"key":"1353_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/1470320309347786","volume":"11","author":"HM Siragy","year":"2010","unstructured":"Siragy HM. The angiotensin II type 2 receptor and the kidney. J Renin-Angiotensin-Aldosterone Syst. 2010;11:33\u20136.","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"key":"1353_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00424-012-1146-3","volume":"465","author":"SH Padia","year":"2013","unstructured":"Padia SH, Carey RM. AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function. Pfl\u00fcgers Archiv-European J Physiol. 2013;465:99\u2013110.","journal-title":"Pfl\u00fcgers Archiv-European J Physiol"},{"key":"1353_CR22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/hr.2009.192","volume":"33","author":"T Tsutamoto","year":"2010","unstructured":"Tsutamoto T, Nishiyama K, Yamaji M, et al. Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventrieular mass index in patients with hypertension. Hypertens Res. 2010;33:118\u201322.","journal-title":"Hypertens Res"},{"issue":"5","key":"1353_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.5761\/atcs.oa.11.01691","volume":"17","author":"A Sezai","year":"2011","unstructured":"Sezai A, Soma M, Hata M, et al. Article effects of Olmesartan on the renin-angiotensin-aldosterone system for patients with essential hypertension after cardiac surgery\u2014 investigation using a candesartan change-over study. Ann Thorac Cardiovasc Surg. 2011;17(5):487\u201393.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"1353_CR24","doi-asserted-by":"publisher","first-page":"F683","DOI":"10.1152\/ajprenal.00503.2009","volume":"298","author":"T Naito","year":"2010","unstructured":"Naito T, Ma LJ, Yang H, et al. Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis. Am J Physiol-Renal Physiol. 2010;298:F683\u201391.","journal-title":"Am J Physiol-Renal Physiol"},{"key":"1353_CR25","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3346\/jkms.2013.28.5.700","volume":"28","author":"HS Kim","year":"2013","unstructured":"Kim HS, No CW, Goo SH, et al. An angiotensin receptor blocker prevents Arrhythmogenic left atrial remodeling in a rat post myocardial infarction induced heart failure model. J Korean Med Sci. 2013;28:700\u20138.","journal-title":"J Korean Med Sci"},{"key":"1353_CR26","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1124\/jpet.103.054916","volume":"307","author":"H Thai","year":"2003","unstructured":"Thai H, Wollmuth J, Goldman S, et al. AT1 receptor blockade improves vasorelaxation in heart failure by up-regulation of endothelial nitric oxide synthase via activation of the AT2 receptor. J Pharmacol Exp Ther. 2003;307:1171\u20138.","journal-title":"J Pharmacol Exp Ther"},{"key":"1353_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000327140","volume":"1","author":"L Pulakat","year":"2011","unstructured":"Pulakat L, Vincent GD, Adam WC, et al. The impact of Overnutrition on insulin metabolic signaling in the heart and the kidney. Cardiorenal Med. 2011;1:102\u201312.","journal-title":"Cardiorenal Med"},{"key":"1353_CR28","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1111\/j.1476-5381.2011.01712.x","volume":"165","author":"H Lu","year":"2012","unstructured":"Lu H, Balakrishnan A, Howatt DA, et al. Comparative effects of different modes of rennin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis. Br J Pharmacol. 2012;165:2000\u20138.","journal-title":"Br J Pharmacol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01353-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-020-01353-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01353-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:11:27Z","timestamp":1614298287000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01353-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,27]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1353"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01353-z","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,27]]},"assertion":[{"value":"17 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experiments of the present study have been approved by the Committee on the Ethics of Animal Experiments of Capital Medical University [approval number: SCXK2006\u20130008].","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}